Supernus Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
SIEBERT JOHN M director
Common Stock 7,000 N/A N/A
Option
BHATT PADMANABH P. officer: Sr. VP of IP, CSO
Common Stock 25,000 N/A N/A
Option
BHATT PADMANABH P. officer: Sr. VP of IP, CSO
Employee Stock Option (right to buy) 25,000 N/A N/A
Purchase
PATRICK GREGORY S officer: Sr. VP Chief Financial..
Common Stock 3,000 N/A N/A
Purchase
KHATTAR JACK A. director, officer: President, CEO
Common Stock 5,000 N/A N/A
Purchase
MARTIN TAMI TILLOTSON officer: Sr. V.P., Regulatory A..
Common Stock 2,500 N/A N/A
Purchase
SIEBERT JOHN M director
Common Stock 3,000 N/A N/A
Purchase
ORBIMED ADVISORS LLC 10 percent owner
Common Stock 1,100,000 N/A N/A
Purchase
NEWHALL CHARLES W III director
Common Stock 4,400,000 N/A N/A
Purchase
BARRETT M JAMES director
Common Stock 4,400,000 N/A N/A
Purchase
NEW ENTERPRISE ASSOCIATES 11 LP 10 percent owner
Common Stock 4,400,000 N/A N/A
Purchase
SHEFFERY MICHAEL B director
Common Stock 1,100,000 N/A N/A
Purchase
NUERGE WILLIAM A. director
Common Stock 15,000 N/A N/A
Purchase
ABINGWORTH MANAGEMENT LTD 10 percent owner
Common Stock, $0.001 par value per share 1,100,000 N/A N/A
Purchase
HUDSON FREDERICK M. director
Common Stock 5,000 N/A N/A

Showing 350 to 365 of 365 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.